318. Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) in Hispanic/Latinx and Black Participants: Efficacy, Bone and Renal Safety Results from a Pooled Analysis of 7 Clinical Trials

BACKGROUND: People of color are underrepresented in clinical trials. TAF has shown improved renal and bone safety vs. TDF. We pooled 7 studies to evaluate efficacy/safety of TAF vs. TDF for ART initiation/switch in Hispanic/Latinx and Black participants. METHODS: Data from Hispanic/Latinx and Black...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Open Forum Infect Dis
Κύριοι συγγραφείς: DeJesus, Edwin, Federico Andrade Villanueva, Jaime, Ramon Arribas Lopez, Jose, Brinson, Cynthia, Crofoot, Gordon, Daar, Eric S, Koenig, Ellen, Podzamczer, Daniel, Ramgopal, Moti, Santana, Jorge, Santiago, Lizette, Tebas, Pablo, Zorrilla, Carmen, Guo, Susan, Liu, Ya-Pei, Zhong, Lijie, Brainard, Diana M, Carter, Christoph C, Temme, Lauren, Das, Moupali
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Oxford University Press 2019
Θέματα:
Abstracts
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6809442/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.391
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια